668
Views
15
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

The effects of the vascular disrupting agents combretastatin A-4 disodium phosphate, 5,6-dimethylxanthenone-4-acetic acid and ZD6126 in a murine tumour: A comparative assessment using MRI and MRS

, , , &
Pages 306-316 | Received 26 Jul 2005, Published online: 26 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Michael R. Horsman. (2016) Realistic biological approaches for improving thermoradiotherapy. International Journal of Hyperthermia 32:1, pages 14-22.
Read now
Lotte B. Bertelsen, Yuan Yuan Shen, Thomas Nielsen, Hans Stødkilde-Jørgensen, G. Kenneth Lloyd, Dietmar W. Siemann & Michael R. Horsman. (2011) Vascular effects of plinabulin (NPI-2358) and the influence on tumour response when given alone or combined with radiation. International Journal of Radiation Biology 87:11, pages 1126-1134.
Read now

Articles from other publishers (13)

Alina Drzyzga, Tomasz Cichoń, Justyna Czapla, Magdalena Jarosz-Biej, Ewelina Pilny, Sybilla Matuszczak, Piotr Wojcieszek, Zbigniew Urbaś & Ryszard Smolarczyk. (2021) The Proper Administration Sequence of Radiotherapy and Anti-Vascular Agent—DMXAA Is Essential to Inhibit the Growth of Melanoma Tumors. Cancers 13:16, pages 3924.
Crossref
Li Liu, Devin O’Kelly, Regan Schuetze, Graham Carlson, Heling Zhou, Mary Lynn Trawick, Kevin G. Pinney & Ralph P. Mason. (2021) Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors. Molecules 26:9, pages 2551.
Crossref
Shixian Lv, Zhaohui Tang, Wantong Song, Dawei Zhang, Mingqiang Li, Huaiyu Liu, Jianjun Cheng, Wu Zhong & Xuesi Chen. (2017) Inhibiting Solid Tumor Growth In Vivo by Non-Tumor-Penetrating Nanomedicine. Small 13:12, pages 1600954.
Crossref
Dietmar W. Siemann & Michael R. Horsman. (2015) Modulation of the tumor vasculature and oxygenation to improve therapy. Pharmacology & Therapeutics 153, pages 107-124.
Crossref
Veerle Kersemans, Bart Cornelissen, Philip D. Allen, John S. Beech & Sean C. Smart. (2013) Subcutaneous tumor volume measurement in the awake, manually restrained mouse using MRI. Journal of Magnetic Resonance Imaging 37:6, pages 1499-1504.
Crossref
Huaijun Wang, Marlein Miranda Cona, Feng Chen, Jie Yu, Yuanbo Feng, Junjie Li, Frederik De Keyzer, Guy Marchal & Yicheng Ni. (2012) Comparison of two vascular-disrupting agents at a clinically relevant dose in rodent liver tumors with multiparametric magnetic resonance imaging biomarkers. Anti-Cancer Drugs 23:1, pages 12-21.
Crossref
Dietmar W. Siemann. (2011) The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents. Cancer Treatment Reviews 37:1, pages 63-74.
Crossref
Ralph P. Mason, Dawen Zhao, Li Liu, Mary Lynn Trawick & Kevin G. Pinney. (2011) A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment. Integrative Biology 3:4, pages 375.
Crossref
Martin Zweifel & Gordon Rustin. 2010. Vascular Disruptive Agents for the Treatment of Cancer. Vascular Disruptive Agents for the Treatment of Cancer 183 216 .
Gianluca Valentini, Cosimo D’Andrea, Raffaele Ferrari, Antonio Pifferi, Rinaldo Cubeddu, Michele Martinelli, Claudia Natoli, Paolo Ubezio & Raffaella Giavazzi. (2008) In Vivo Measurement of Vascular Modulation in Experimental Tumors Using a Fluorescent Contrast Agent . Photochemistry and Photobiology 84:5, pages 1249-1256.
Crossref
Simon P. Robinson, Franklyn A. Howe, John R. Griffiths, Anderson J. Ryan & John C. Waterton. (2007) Susceptibility Contrast Magnetic Resonance Imaging Determination of Fractional Tumor Blood Volume: A Noninvasive Imaging Biomarker of Response to the Vascular Disrupting Agent ZD6126. International Journal of Radiation Oncology*Biology*Physics 69:3, pages 872-879.
Crossref
Michael R. Horsman & Dietmar W. Siemann. (2006) Pathophysiologic Effects of Vascular-Targeting Agents and the Implications for Combination with Conventional Therapies. Cancer Research 66:24, pages 11520-11539.
Crossref
Basetti Madhu, John C. Waterton, John R. Griffiths, Anderson J. Ryan & Simon P. Robinson. (2006) The Response of RIF-1 Fibrosarcomas to the Vascular-Disrupting Agent ZD6126 Assessed by In Vivo and Ex Vivo1H Magnetic Resonance Spectroscopy. Neoplasia 8:7, pages 560-567.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.